Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in Drug-Resistant Unipolar Depression
NCT01135758Phase 2Terminated
- Sponsor
- Markus Kosel
- Start
- Jun 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), sponsored by Markus Kosel. Started Jun 2010; status: terminated.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01135758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135758.